Skip to content
MedsAcross

Medicine

Mesalamine 1000 mg suppository

Mesalamine · Rectal
Available on requestPrescription onlyUS FDA Cold chainGeneric name

Mesalamine 1000 mg suppository is a generic prescription medicine for rectal use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Cold chain

Store below 25°C (77°F), may be refrigerated.

Key facts

Active ingredient (INN)
Mesalamine
Brand
Sold under the generic name
Strength
1000 mg
Dosage form
Suppository
Route
Rectal
Packs
5 blister pack, 5 package, 7 package and 6 more
Manufacturers
Camber PharmaceuticalsIndiaZydus LifesciencesIndiaRising Pharma HoldingsActavis PharmaBryant Ranch PrepackNorthStar Rx
Origin register
US FDA, United States
Storage
Store below 25°C (77°F), may be refrigerated.
Cold chain
Yes, shipped temperature controlled
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
A07EC02 Mesalamine
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
5 June 2019
Identifiers
RxCUI 248420DailyMed set ID 73317da3-cba0-4106-9e88-79b0e2f642af, 7ac78fa0-60a8-48dd-abc4-a487f98039a2, f458d574-7b5b-44f1-86be-8b18880dc67f +4NDC 0472-1915, 16714-245, 70710-1302 +4Application ANDA205654, ANDA208953, ANDA219028 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
5 blister pack in 1 pouch / 6 suppository in 1 blister pack70710-1302-7Zydus LifesciencesIndia14 February 2020
5 blister pack in 1 pouch / 6 suppository in 1 blister pack70771-1513-7Zydus LifesciencesIndia14 February 2020
5 package in 1 carton / 6 suppository in 1 package31722-005-30Camber PharmaceuticalsIndia19 March 2020
7 package in 1 carton / 6 suppository in 1 package31722-005-31Camber PharmaceuticalsIndia19 March 2020
30 pouch in 1 box / 1 suppository in 1 pouch0472-1915-30Actavis Pharma23 April 2021
5 blister pack in 1 carton / 6 suppository in 1 blister pack16571-246-03Rising Pharma Holdings14 April 2025
12 blister pack in 1 carton / 6 suppository in 1 blister pack16571-246-72Rising Pharma Holdings14 April 2025
5 package in 1 carton / 6 suppository in 1 package63629-2397-1Bryant Ranch Prepack4 May 2021
5 blister pack in 1 pouch / 6 suppository in 1 blister pack16714-245-30Northstar Rx25 August 2021

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 24 December 1987Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Mesalamine 1000 mg suppository.

Compare all 2

Other strengths and forms of Mesalamine

Clinical summary

Mesalamine is an aminosalicylate indicated for the treatment of active mild to moderate distal ulcerative colitis, proctosigmoiditis or proctitis in adults. It is available as delayed-release tablets, extended-release capsules and suppositories for oral and rectal use. MedsAcross supplies Mesalamine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Mesalamine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Mesalamine 1000 mg suppository for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.